Mr Jingsaidthefirstphaseof thetrialwouldlastaboutthreeyears and would involve restricted areas in the city where buses, mid-sizevansandcarswouldbe tested.
The trial's first phase, which could last up to three months, is designed to identify causes of the blowout and assign percentages of blame to the companies involved.
Just three months before its planned split into two companies, Abbott Laboratories is suffering a significant setback after a Phase III trial for a chronic kidney disease treatment was ended due to an excessive number of deaths and serious adverse events in patients.